Cargando…

Case Report—Secondary Antibody Deficiency Due to Endogenous Hypercortisolism

Therapeutic corticosteroids have an immunosuppressive function involving several pathways, including lymphocytopenia and hypogammaglobulinemia. While these effects have been well-described in patients that received corticosteroids for therapeutic reasons, the effects of endogenous corticosteroids on...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarcevic, Jelena, Cavelti-Weder, Claudia, Berger, Christoph T., Trendelenburg, Marten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358340/
https://www.ncbi.nlm.nih.gov/pubmed/32733476
http://dx.doi.org/10.3389/fimmu.2020.01435
_version_ 1783558832160505856
author Sarcevic, Jelena
Cavelti-Weder, Claudia
Berger, Christoph T.
Trendelenburg, Marten
author_facet Sarcevic, Jelena
Cavelti-Weder, Claudia
Berger, Christoph T.
Trendelenburg, Marten
author_sort Sarcevic, Jelena
collection PubMed
description Therapeutic corticosteroids have an immunosuppressive function involving several pathways, including lymphocytopenia and hypogammaglobulinemia. While these effects have been well-described in patients that received corticosteroids for therapeutic reasons, the effects of endogenous corticosteroids on the immune system are less well-understood. Here, we describe a 21-year old patient with hypercortisolism due to an ACTH producing thymic tumor. In this patient, we observed a decrease in some of the immunoglobulin classes, and in specific B and T cell populations that resembled effects caused by corticosteroid treatment. IgG levels were restored following treatment and normalization of the hypercortisolism.
format Online
Article
Text
id pubmed-7358340
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-73583402020-07-29 Case Report—Secondary Antibody Deficiency Due to Endogenous Hypercortisolism Sarcevic, Jelena Cavelti-Weder, Claudia Berger, Christoph T. Trendelenburg, Marten Front Immunol Immunology Therapeutic corticosteroids have an immunosuppressive function involving several pathways, including lymphocytopenia and hypogammaglobulinemia. While these effects have been well-described in patients that received corticosteroids for therapeutic reasons, the effects of endogenous corticosteroids on the immune system are less well-understood. Here, we describe a 21-year old patient with hypercortisolism due to an ACTH producing thymic tumor. In this patient, we observed a decrease in some of the immunoglobulin classes, and in specific B and T cell populations that resembled effects caused by corticosteroid treatment. IgG levels were restored following treatment and normalization of the hypercortisolism. Frontiers Media S.A. 2020-07-07 /pmc/articles/PMC7358340/ /pubmed/32733476 http://dx.doi.org/10.3389/fimmu.2020.01435 Text en Copyright © 2020 Sarcevic, Cavelti-Weder, Berger and Trendelenburg. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Sarcevic, Jelena
Cavelti-Weder, Claudia
Berger, Christoph T.
Trendelenburg, Marten
Case Report—Secondary Antibody Deficiency Due to Endogenous Hypercortisolism
title Case Report—Secondary Antibody Deficiency Due to Endogenous Hypercortisolism
title_full Case Report—Secondary Antibody Deficiency Due to Endogenous Hypercortisolism
title_fullStr Case Report—Secondary Antibody Deficiency Due to Endogenous Hypercortisolism
title_full_unstemmed Case Report—Secondary Antibody Deficiency Due to Endogenous Hypercortisolism
title_short Case Report—Secondary Antibody Deficiency Due to Endogenous Hypercortisolism
title_sort case report—secondary antibody deficiency due to endogenous hypercortisolism
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7358340/
https://www.ncbi.nlm.nih.gov/pubmed/32733476
http://dx.doi.org/10.3389/fimmu.2020.01435
work_keys_str_mv AT sarcevicjelena casereportsecondaryantibodydeficiencyduetoendogenoushypercortisolism
AT caveltiwederclaudia casereportsecondaryantibodydeficiencyduetoendogenoushypercortisolism
AT bergerchristopht casereportsecondaryantibodydeficiencyduetoendogenoushypercortisolism
AT trendelenburgmarten casereportsecondaryantibodydeficiencyduetoendogenoushypercortisolism